[cité 9 déc 2015]. http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et- traumatismes ,
Synthése épidémiologique. [cité 16 déc 2015 ,
http://www.invs.sante.fr/fr/Dossiers-thematiques/Maladies-chroniques-et- traumatismes, 2007. ,
Améliorer la qualité du système de santé et maîtriser les dépenses. [cité 13 déc 2015 ,
Clinical Inertia in People With Type 2 Diabetes: A retrospective cohort study of more than 80,000 people, Diabetes Care, vol.36, issue.11, pp.3411-3418, 2013. ,
DOI : 10.2337/dc13-0331
Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes, Cardiovascular Diabetology, vol.311, issue.22, p.100, 2015. ,
DOI : 10.1186/s12933-015-0260-x
Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations, Annals of Internal Medicine, vol.154, issue.9, pp.602-615 ,
DOI : 10.7326/0003-4819-154-9-201105030-00336
A decision tool to support appropriate referral for deep brain stimulation in Parkinson???s disease, Journal of Neurology, vol.125, issue.1, pp.83-91, 2009. ,
DOI : 10.1007/s00415-009-0069-1
Evaluation of a computer-based decision support system for treatment of hypertension with drugs: retrospective, nonintervention testing of cost and guideline adherence, Journal of Internal Medicine, vol.7, issue.1, pp.87-93, 2000. ,
DOI : 10.1046/j.1365-2796.2000.00581.x
Design of a Decision Support System to Help Clinicians Manage Glycemia in Patients with Type 2 Diabetes Mellitus, Journal of Diabetes Science and Technology, vol.4, issue.2, p.402, 2011. ,
DOI : 10.1056/NEJMoa0808431
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes, JAMA, vol.293, issue.10 ,
DOI : 10.1001/jama.293.10.1223
Stratégie médicamenteuse du contrôle glycémique du diabète de type 2, 2015. ,
A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes, Diabetes Technology & Therapeutics, vol.17, issue.3, p.194, 2015. ,
DOI : 10.1089/dia.2014.0260
Developing a Quality Measure for Clinical Inertia in Diabetes Care, Health Services Research, vol.23, issue.7, p.1836, 2005. ,
DOI : 10.1056/NEJM199309303291401
Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks, Diabetes, Obesity and Metabolism, vol.12, issue.Suppl. 2, pp.567-76, 2011. ,
DOI : 10.1111/j.1463-1326.2011.01385.x
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy, Diabetes, Obesity and Metabolism, vol.30, issue.2, pp.157-66, 2009. ,
DOI : 10.1111/j.1463-1326.2008.00994.x
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 ,
Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes, JAMA, vol.316, issue.3, pp.313-337, 201619. ,
DOI : 10.1001/jama.2016.9400